Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.

A set of minimum clinical guidelines for use by primary care physicians in the evaluation and management of patients with thyroid nodules or thyroid cancer was developed by consensus by an 11-member Standards of Care Committee (the authors of the article) of the American Thyroid Association, New York, NY. The participants were selected by the committee chairman and by the president of the American Thyroid Association based on their clinical experience. The committee members represented different geographic areas within the United States, to reflect different practice patterns. The guidelines were developed based on the expert opinion of the committee participants, as well as on previously published information. Each committee participant was initially assigned to write a section of the document and to submit it to the committee chairman, who revised and assembled the sections into a complete draft document, which was then circulated among all committee members for further revision. Several of the committee members further revised and refined the document, which was then submitted to the entire membership of the American Thyroid Association for written comments and suggestions, many of which were incorporated into a final draft document, which was reviewed and approved by the Executive Council of the American Thyroid Association.

[1]  I. Hay Papillary Thyroid Carcinoma , 1990 .

[2]  E. Kaplan,et al.  Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.

[3]  I. Narabayashi,et al.  Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. , 1993, Thyroid : official journal of the American Thyroid Association.

[4]  B. Biondi,et al.  Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine* , 1993 .

[5]  N. Ordóñez,et al.  Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. , 1996, Endocrinology and metabolism clinics of North America.

[6]  E. Mazzaferri,et al.  Management of a solitary thyroid nodule. , 1993, The New England journal of medicine.

[7]  P. McCarthy,et al.  Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. , 1989, Surgery.

[8]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[9]  T. Panzarella,et al.  Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. , 1988, International journal of radiation oncology, biology, physics.

[10]  E. Mazzaferri,et al.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. , 1981, The American journal of medicine.

[11]  T. Miyamoto,et al.  Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. , 1994, The Journal of clinical endocrinology and metabolism.

[12]  H. Gharib,et al.  Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases. , 1985, Mayo Clinic proceedings.

[13]  J. Hershman,et al.  Medical therapy for differentiated thyroid carcinoma. , 1994, Endocrine reviews.

[14]  D. Cooper Thyrosine suppression therapy for benign nodular disease , 1995 .

[15]  E. Mazzaferri,et al.  Pure follicular thyroid carcinoma: impact of therapy in 214 patients. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  J. Barentsz,et al.  Large, Compressive Goiters Treated with Radioiodine , 1994, Annals of Internal Medicine.

[17]  L. Wartofsky Use of sensitive TSH assay to determine optimal thyroid hormone therapy and avoid osteoporosis. , 1991, Annual review of medicine.

[18]  H. Gharib,et al.  Fine-Needle Aspiration Biopsy of the Thyroid: An Appraisal , 1993, Annals of Internal Medicine.

[19]  S. Refetoff,et al.  Serum thyroglobulin in the management of patients with thyroid cancer. , 1982, Archives of internal medicine.

[20]  D. Cooper Clinical review 66: Thyroxine suppression therapy for benign nodular disease. , 1995, The Journal of clinical endocrinology and metabolism.

[21]  D. Ross Thyroid hormone suppressive therapy of sporadic nontoxic goiter. , 1992, Thyroid : official journal of the American Thyroid Association.